Eric Aguiar - Net Worth and Insider Trading

Eric Aguiar Net Worth

The estimated net worth of Eric Aguiar is at least $3.0 Billion dollars as of 2024-04-24. Eric Aguiar is the Director, 10% Owner of Eidos Therapeutics Inc and owns about 24,575,501 shares of Eidos Therapeutics Inc (EIDX) stock worth over $3.0 Billion. Eric Aguiar is the Director of Biohaven Pharmaceutical Holding Co Ltd and owns about 1,250 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $17,600. Eric Aguiar is also the Director of Invitae Corp and owns about 0 shares of Invitae Corp (NVTAQ) stock worth over $0. Details can be seen in Eric Aguiar's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Eric Aguiar has not made any transactions after 2020-12-16 and currently still holds the listed stock(s).

Transaction Summary of Eric Aguiar

To

Eric Aguiar Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eric Aguiar owns 8 companies in total, including Invitae Corp (NVTAQ) , BridgeBio Pharma Inc (BBIO) , and Eidos Therapeutics Inc (EIDX) among others .

Click here to see the complete history of Eric Aguiar’s form 4 insider trades.

Insider Ownership Summary of Eric Aguiar

Ticker Comapny Transaction Date Type of Owner
NVTAQ Invitae Corp 2020-12-16 director
BBIO BridgeBio Pharma Inc 2019-06-27 director
EIDX Eidos Therapeutics Inc 2020-05-27 director
BHVN Biohaven Pharmaceutical Holding Co Ltd 2020-01-22 director
OCRX Ocera Therapeutics Inc 2013-07-15 10 percent owner
ALT Altimmune Inc 2007-08-02 other: member of Section 13(d) group
CSII Cardiovascular Systems Inc 2006-06-27 10 percent owner
BMEA Biomea Fusion Inc 2021-04-15 director

Eric Aguiar Latest Holdings Summary

Eric Aguiar currently owns a total of 3 stocks. Among these stocks, Eric Aguiar owns 24,575,501 shares of Eidos Therapeutics Inc (EIDX) as of July 3, 2019, with a value of $3.0 Billion and a weighting of 100%. Eric Aguiar owns 1,250 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of January 22, 2020, with a value of $17,600 and a weighting of 0%. Eric Aguiar also owns 0 shares of Invitae Corp (NVTAQ) as of December 16, 2020, with a value of $0 and a weighting of 0%.

Latest Holdings of Eric Aguiar

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EIDX Eidos Therapeutics Inc 2019-07-03 24,575,501 122.21 3,003,371,977
BHVN Biohaven Pharmaceutical Holding Co Ltd 2020-01-22 1,250 14.08 17,600
NVTAQ Invitae Corp 2020-12-16 0 0.00 0

Holding Weightings of Eric Aguiar


Eric Aguiar Form 4 Trading Tracker

According to the SEC Form 4 filings, Eric Aguiar has made a total of 2 transactions in Eidos Therapeutics Inc (EIDX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Eidos Therapeutics Inc is the acquisition of 882,353 shares on July 3, 2019, which cost Eric Aguiar around $26 Million.

According to the SEC Form 4 filings, Eric Aguiar has made a total of 6 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the sale of 2,021 shares on January 22, 2020, which brought Eric Aguiar around $114,146.

According to the SEC Form 4 filings, Eric Aguiar has made a total of 3 transactions in Invitae Corp (NVTAQ) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Invitae Corp is the sale of 10,000 shares on December 16, 2020, which brought Eric Aguiar around $510,000.

Insider Trading History of Eric Aguiar

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eric Aguiar Trading Performance

GuruFocus tracks the stock performance after each of Eric Aguiar's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric Aguiar is 36.64%. GuruFocus also compares Eric Aguiar's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric Aguiar within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Eric Aguiar's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Eric Aguiar

Average Return

41.57%

Average return per transaction

Outperforming Transactions

100%

3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.73 36.64 63.31 41.57 47.97 44.44
Relative Return to S&P 500(%) -1.13 34.75 54.49 32.49 35.95 31.75

Eric Aguiar Ownership Network

Ownership Network List of Eric Aguiar

No Data

Ownership Network Relation of Eric Aguiar


Eric Aguiar Owned Company Details

What does Invitae Corp do?

Who are the key executives at Invitae Corp?

Eric Aguiar is the director of Invitae Corp. Other key executives at Invitae Corp include Chief Financial Officer Ana J. Schrank , Chief Commercial Officer Robert M. Guigley , and See Remarks Robert Iv Dickey .

Invitae Corp (NVTAQ) Insider Trades Summary

Over the past 18 months, Eric Aguiar made no insider transaction in Invitae Corp (NVTAQ). Other recent insider transactions involving Invitae Corp (NVTAQ) include a net sale of 92,717 shares made by Kenneth D. Knight , a net sale of 89,529 shares made by Yafei Wen , and a net sale of 36,187 shares made by Robert L Nussbaum .

In summary, during the past 3 months, insiders sold 0 shares of Invitae Corp (NVTAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 332,151 shares of Invitae Corp (NVTAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 332,151 shares.

Invitae Corp (NVTAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Invitae Corp Insider Transactions

No Available Data

Eric Aguiar Mailing Address

Above is the net worth, insider trading, and ownership report for Eric Aguiar. You might contact Eric Aguiar via mailing address: 888 7th Avenue, 12th Floor, New York Ny 10106.

Discussions on Eric Aguiar

No discussions yet.